107
Views
16
CrossRef citations to date
0
Altmetric
Original Research

Mangiferin Mitigates Lipopolysaccharide-Induced Lung Injury by Inhibiting NLRP3 Inflammasome Activation

, , , , &
Pages 2289-2300 | Published online: 31 May 2021

References

  • Matthay M, Arabi Y, Siegel E, et al. Phenotypes and personalized medicine in the acute respiratory distress syndrome. Intensive Care Med. 2020;46(12):2136–2152. doi:10.1007/s00134-020-06296-9
  • Matthay M, Ware L, Zimmerman G. The acute respiratory distress syndrome. J Clin Invest. 2012;122(8):2731–2740. doi:10.1172/JCI60331
  • Zhang D, Song D, Shi L, et al. Mechanisms of interactions between lung-origin telocytes and mesenchymal stem cells to treat experimental acute lung injury. Clin Transl Med. 2020;10(8):e231. doi:10.1002/ctm2.231
  • Feng Y, Tan Z, Wu L, Dong F, Zhang F. The involvement of NLRP3 inflammasome in the treatment of Alzheimer’s disease. Ageing Res Rev. 2020;64:101192. doi:10.1016/j.arr.2020.101192
  • Chauhan D, Vande Walle L, Lamkanfi M. Therapeutic modulation of inflammasome pathways. Immunol Rev. 2020;297(1):123–138. doi:10.1111/imr.12908
  • Ning L, Wei W, Wenyang J, Rui X, Qing G. Cytosolic DNA-STING-NLRP3 axis is involved in murine acute lung injury induced by lipopolysaccharide. Clin Transl Med. 2020;10(7):e228. doi:10.1002/ctm2.228
  • Ying Y, Mao Y, Yao M. NLRP3 inflammasome activation by MicroRNA-495 promoter methylation may contribute to the progression of acute lung injury. Mol Ther Nucleic Acids. 2019;18:801–814. doi:10.1016/j.omtn.2019.08.028
  • Imran M, Arshad M, Butt M, Kwon J, Arshad M, Sultan M. Mangiferin: a natural miracle bioactive compound against lifestyle related disorders. Lipids Health Dis. 2017;16(1):84. doi:10.1186/s12944-017-0449-y
  • Zhang L, Huang C, Fan S. Mangiferin and organ fibrosis: a mini review. Biofactors. 2020.
  • Naraki K, Rezaee R, Mashayekhi-Sardoo H, Hayes A, Karimi G. Mangiferin offers protection against deleterious effects of pharmaceuticals, heavy metals, and environmental chemicals. Phytother Res. 2020;35(2):810–822. doi:10.1002/ptr.6864
  • Fan K, Ma J, Xiao W, et al. Mangiferin attenuates blast-induced traumatic brain injury via inhibiting NLRP3 inflammasome. Chem Biol Interact. 2017;271:15–23. doi:10.1016/j.cbi.2017.04.021
  • Song J, Li J, Hou F, Wang X, Liu B. Mangiferin inhibits endoplasmic reticulum stress-associated thioredoxin-interacting protein/NLRP3 inflammasome activation with regulation of AMPK in endothelial cells. Metabolism. 2015;64(3):428–437. doi:10.1016/j.metabol.2014.11.008
  • Dong M, Li L, Li G, et al. viaMangiferin protects against alcoholic liver injury suppression of inflammation-induced adipose hyperlipolysis. Food Funct. 2020;11(10):8837–8851. doi:10.1039/D0FO01436B
  • Duan J, Zhou Y, Zhou A, et al. Calcitonin gene-related peptide exerts anti-inflammatory property through regulating murine macrophages polarization in vitro. Mol Immunol. 2017;91:105–113. doi:10.1016/j.molimm.2017.08.020
  • Surabhi S, Cuypers F, Hammerschmidt S, Siemens N. The role of NLRP3 inflammasome in pneumococcal infections. Front Immunol. 2020;11:614801. doi:10.3389/fimmu.2020.614801
  • Zhang Y, Li X, Grailer J, et al. Melatonin alleviates acute lung injury through inhibiting the NLRP3 inflammasome. J Pineal Res. 2016;60(4):405–414. doi:10.1111/jpi.12322
  • Mahalanobish S, Saha S, Dutta S, Sil P. Mangiferin alleviates arsenic induced oxidative lung injury via upregulation of the Nrf2-HO1 axis. Food Chem Toxicol. 2019;126:41–55. doi:10.1016/j.fct.2019.02.022
  • Zou B, Wang H, Liu Y, et al. Mangiferin induces apoptosis in human ovarian adenocarcinoma OVCAR3 cells via the regulation of Notch3. Oncol Rep. 2017;38(3):1431–1441. doi:10.3892/or.2017.5814
  • Jia L, Sun P, Gao H, et al. Mangiferin attenuates bleomycin-induced pulmonary fibrosis in mice through inhibiting TLR4/p65 and TGF-β1/Smad2/3 pathway. J Pharm Pharmacol. 2019;71(6):1017–1028. doi:10.1111/jphp.13077
  • Wu J, Sun J, Meng X. Pyroptosis by caspase-11 inflammasome-gadermin D pathway in autoimmune diseases. Pharmacol Res. 2021;165:105408. doi:10.1016/j.phrs.2020.105408
  • Zhang Z, Zhang Y, Lieberman J. Lighting a fire: can we harness pyroptosis to ignite antitumor immunity? Cancer Immunol Res. 2021;9(1):2–7. doi:10.1158/2326-6066.CIR-20-0525
  • Kist M, Vucic D. Cell death pathways: intricate connections and disease implications. EMBO J. 2021;40(5):e106700. doi:10.15252/embj.2020106700
  • Camilli G, Blagojevic M, Naglik J, Richardson J. Programmed cell death: central player in fungal infections. Trends Cell Biol. 2020;31(3):179–196. doi:10.1016/j.tcb.2020.11.005
  • Tang R, Xu J, Zhang B, et al. Ferroptosis, necroptosis, and pyroptosis in anticancer immunity. J Hematol Oncol. 2020;13(1):110. doi:10.1186/s13045-020-00946-7
  • Abu Khweek A, Amer A. Pyroptotic and non-pyroptotic effector functions of caspase-11. Immunol Rev. 2020;297(1):39–52. doi:10.1111/imr.12910
  • Kovarova M, Hesker P, Jania L, et al. NLRP1-dependent pyroptosis leads to acute lung injury and morbidity in mice. J Immunol. 2012;189(4):2006–2016. doi:10.4049/jimmunol.1201065
  • He Y, Xu K, Wang Y, et al. AMPK as a potential pharmacological target for alleviating LPS-induced acute lung injury partly via NLRC4 inflammasome pathway inhibition. Exp Gerontol. 2019;125:110661. doi:10.1016/j.exger.2019.110661
  • Zhang H, Luo J, Alcorn J, et al. AIM2 inflammasome is critical for influenza-induced lung injury and mortality. J Immunol. 2017;198(11):4383–4393. doi:10.4049/jimmunol.1600714